You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tuberous Sclerosis

Showing 1 - 25 of 3,695
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

Recruiting
  • Tuberous Sclerosis Complex
  • Acceptance and Commitment Therapy (ACT)
  • Bristol, United Kingdom
    University Hospitals Bristol and Weston NHS Trust
May 10, 2023

Study of Skin Tumors in Tuberous Sclerosis

Recruiting
  • Tuberous Sclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)

    Recruiting
    • TSC
    • Behavioral Symptoms
    • Behavioral Intervention in a small group platform
    • Carrboro, North Carolina
    • +1 more
    Oct 23, 2023

    Studies in Patients With Tuberous Sclerosis Complex

    Recruiting
    • Tuberous Sclerosis Complex
      • Phoenix, Arizona
        Translational Genomics Research Institute (TGen)
      Oct 18, 2022

      Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

      Not yet recruiting
      • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
      • Cannabidiol Oral Solution [Epidiolex]
      • Los Angeles, California
      • +6 more
      May 9, 2023

      Renal Angiomyolipoma Trial (Everolimus)

      Not yet recruiting
      • Renal Angiomyolipoma
      • (no location specified)
      Aug 15, 2022

      Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)

      Not yet recruiting
      • Tuberous Sclerosis Complex
      • Rapamycin
      • Placebo
      • Lodz, Poland
      • +1 more
      Sep 6, 2022

      Tuberous Sclerosis Complex, Seizures Trial in Boston (GWP42003-P)

      Completed
      Has Results
      • Tuberous Sclerosis Complex
      • Seizures
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jul 12, 2022

      Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

      Recruiting
      • Tuberous Sclerosis Complex
      • NPC-12Y gel
      • NPC-12Y placebo gel
      • Toyoake, Aichi, Japan
      • +4 more
      Aug 8, 2022

      Study of the Disease Process of Lymphangioleiomyomatosis

      Recruiting
      • Lung Disease
      • +3 more
      • Toshibia Aquilion One CT
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

      Recruiting
      • Lymphangioleiomyomatosis
      • Tuberous Sclerosis Complex
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 20, 2022

      Lymphangioleiomyomatosis, a Study on Cathepsin K

      Recruiting
      • Lymphangioleiomyomatosis
      • Tuberous Sclerosis Complex
      • 24h urine
      • urine sample
      • Tours, France
        University hospital
      Jul 18, 2022

      Role of Genetic Factors in the Development of Lung Disease

      Recruiting
      • Cystic Fibrosis
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis, Hamartoma Syndrome, Multiple Trial in Chicago (Functional Behavioral

        Enrolling by invitation
        • Telomeric 22Q13 Monosomy Syndrome
        • +7 more
        • Functional Behavioral Training (FBT)
        • Positive Parenting Strategies-Treatment as Usual
        • Chicago, Illinois
          Autism Assessment Research Treatment and Services (AARTS) Center
        Nov 14, 2023

        Tuberous Sclerosis Trial in United States (Ganaxolone)

        Completed
        • Tuberous Sclerosis
        • Los Angeles, California
        • +6 more
        Oct 27, 2022

        Seizure in Participants With Tuberous Sclerosis Complex Trial in United States (GWP42003-P, SOC)

        Recruiting
        • Seizure in Participants With Tuberous Sclerosis Complex
        • Little Rock, Arkansas
        • +3 more
        Jul 6, 2022

        Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)

        Active, not recruiting
        • Tuberous Sclerosis Complex
        • Birmingham, Alabama
        • +12 more
        May 4, 2022

        Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

        Completed
        • Facial Angiofibroma
        • Tuberous Sclerosis
        • Phoenix, Arizona
        • +16 more
        Jul 26, 2022

        Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

        Recruiting
        • Angiofibroma of Face
        • Tuberous Sclerosis
        • Sirolimus 0.2%
        • +2 more
        • Phoenix, Arizona
        • +7 more
        Feb 2, 2022

        Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

        Active, not recruiting
        • Hypomelanotic Macules
        • +8 more
          • Tirana, Albania
          • +7 more
          Mar 23, 2022

          Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

          Enrolling by invitation
          • Tuberous Sclerosis Complex
          • Phoenix, Arizona
          • +13 more
          Jan 24, 2023

          Data Set Re-use With Statistical Methodologies Tailored for

          Recruiting
          • Tuberous Sclerosis
          • Epilepsy
            • Paris, France
              Rima Nabbout
            Jan 5, 2022

            Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

            Recruiting
            • Tuberous Sclerosis Complex
            • Epilepsy
            • Birmingham, Alabama
            • +7 more
            Sep 2, 2022

            Chronic Kidney Diseases, Diabetes, Arterial Hypertension Trial in Bari (KidneYou APP)

            Recruiting
            • Chronic Kidney Diseases
            • +12 more
            • KidneYou APP
            • Bari, Italy
              U.O. Nefrologia
            Jul 19, 2022

            Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

            Active, not recruiting
            • Tuberous Sclerosis Complex
            • Epilepsy
            • TAVT-18 (sirolimus)
            • Cincinnati, Ohio
              Cincinnati Children's Hospital
            Jan 10, 2022